HomeHRMY • NASDAQ
add
Harmony Biosciences Holdings Inc
Previous close
$34.23
Day range
$33.69 - $35.30
Year range
$26.47 - $41.61
Market cap
2.01B USD
Avg Volume
763.07K
P/E ratio
13.37
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 184.73M | 19.48% |
Operating expense | 96.49M | 28.49% |
Net income | 45.56M | 18.85% |
Net profit margin | 24.66 | -0.52% |
Earnings per share | 1.03 | 17.05% |
EBITDA | 62.21M | 6.97% |
Effective tax rate | 20.32% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 506.95M | 36.15% |
Total assets | 1.06B | 24.62% |
Total liabilities | 335.01M | 1.03% |
Total equity | 720.52M | — |
Shares outstanding | 57.42M | — |
Price to book | 2.73 | — |
Return on assets | 13.69% | — |
Return on capital | 16.18% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 45.56M | 18.85% |
Cash from operations | 33.99M | 9.14% |
Cash from investing | 2.36M | 138.18% |
Cash from financing | -352.00K | 90.31% |
Net change in cash | 36.00M | 68.83% |
Free cash flow | 26.49M | -1.84% |
About
Founded
2017
Website
Employees
268
